17-alpha-Hydroxyprogesterone
The therapeutic efficacy of Rivaroxaban can be decreased when used in combination with Hydroxyprogesterone caproate.
3-N-Butylphthalide
Butylphthalide may increase the anticoagulant activities of Rivaroxaban.
Abacavir
The serum concentration of Abacavir can be decreased when it is combined with Rivaroxaban.
Advertisement
Abciximab
Abciximab may increase the anticoagulant activities of Rivaroxaban.
Aceclofenac
Aceclofenac may increase the anticoagulant activities of Rivaroxaban.
Acemetacin
The risk or severity of bleeding can be increased when Rivaroxaban is combined with Acemetacin.
Advertisement
Acenocoumarol
Acenocoumarol may increase the anticoagulant activities of Rivaroxaban.
Acetyl salicylate
Acetylsalicylic acid may increase the anticoagulant activities of Rivaroxaban.
Adapalene
Adapalene may increase the anticoagulant activities of Rivaroxaban.
Advertisement
Alfuzosin
The serum concentration of Alfuzosin can be increased when it is combined with Rivaroxaban.
Allylestrenol
The therapeutic efficacy of Rivaroxaban can be decreased when used in combination with Allylestrenol.
Alminoprofen
Alminoprofen may increase the anticoagulant activities of Rivaroxaban.
Aloxiprin
Aloxiprin may increase the anticoagulant activities of Rivaroxaban.
alpha Tocopherol
Vitamin E may increase the anticoagulant activities of Rivaroxaban.
Alprazolam
The serum concentration of Alprazolam can be increased when it is combined with Rivaroxaban.
Alprostadil
Alprostadil may increase the anticoagulant activities of Rivaroxaban.
Alteplase
Alteplase may increase the anticoagulant activities of Rivaroxaban.
AMBROXOL ACEFYLLINATE
The serum concentration of Ambroxol acefyllinate can be decreased when it is combined with Rivaroxaban.
Ambroxol-Theophylline-7-Acetate
The serum concentration of Ambroxol acefyllinate can be decreased when it is combined with Rivaroxaban.
Amineptin
The serum concentration of Amineptine can be increased when it is combined with Rivaroxaban.
Aminophylline
The serum concentration of Aminophylline can be decreased when it is combined with Rivaroxaban.
Aminosalicylic Acid
Aminosalicylic Acid may increase the anticoagulant activities of Rivaroxaban.
Amiodarone
The metabolism of Rivaroxaban can be decreased when combined with Amiodarone.
Amitriptyline
The serum concentration of Amitriptyline can be increased when it is combined with Rivaroxaban.
Amoxapine
The serum concentration of Amoxapine can be increased when it is combined with Rivaroxaban.
Anagrelide
Anagrelide may increase the anticoagulant activities of Rivaroxaban.
Ancrod
Ancrod may increase the anticoagulant activities of Rivaroxaban.
Anhydrous Tacrolimus
The metabolism of Tacrolimus can be decreased when combined with Rivaroxaban.
Anistreplase
Anistreplase may increase the anticoagulant activities of Rivaroxaban.
Antipyrine
Antipyrine may increase the anticoagulant activities of Rivaroxaban.
Antithrombin III
Antithrombin III human may increase the anticoagulant activities of Rivaroxaban.
Antithrombin III, Human
Antithrombin III human may increase the anticoagulant activities of Rivaroxaban.
Apalutamide
The serum concentration of Rivaroxaban can be decreased when it is combined with Apalutamide.
Apazone
Azapropazone may increase the anticoagulant activities of Rivaroxaban.
Apixaban
Apixaban may increase the anticoagulant activities of Rivaroxaban.
Apremilast
Apremilast may increase the anticoagulant activities of Rivaroxaban.
Aprepitant
The serum concentration of Rivaroxaban can be increased when it is combined with Aprepitant.
Aprotinin
The therapeutic efficacy of Rivaroxaban can be decreased when used in combination with Aprotinin.
Ardeparin
Ardeparin may increase the anticoagulant activities of Rivaroxaban.
Argatroban
Argatroban may increase the anticoagulant activities of Rivaroxaban.
Argatroban Anhydrous
Argatroban may increase the anticoagulant activities of Rivaroxaban.
Aspirin
Acetylsalicylic acid may increase the anticoagulant activities of Rivaroxaban.
Astaxanthin
Astaxanthin may increase the anticoagulant activities of Rivaroxaban.
Atazanavir
The metabolism of Rivaroxaban can be decreased when combined with Atazanavir.
Atomoxetine
The metabolism of Rivaroxaban can be decreased when combined with Atomoxetine.
Azelastine
Azelastine may increase the anticoagulant activities of Rivaroxaban.
azficel-T
The risk or severity of adverse effects can be increased when Rivaroxaban is combined with Azficel-T.
Balsalazide
Balsalazide may increase the anticoagulant activities of Rivaroxaban.
Becaplermin
Becaplermin may increase the anticoagulant activities of Rivaroxaban.
Bemiparin
Bemiparin may increase the anticoagulant activities of Rivaroxaban.
Benzydamine
Benzydamine may increase the anticoagulant activities of Rivaroxaban.
Betrixaban
The risk or severity of bleeding can be increased when Betrixaban is combined with Rivaroxaban.
Bivalirudin
Bivalirudin may increase the anticoagulant activities of Rivaroxaban.
Boceprevir
The serum concentration of Rivaroxaban can be decreased when it is combined with Boceprevir.
Bortezomib
The metabolism of Rivaroxaban can be decreased when combined with Bortezomib.
Bosentan
The serum concentration of Rivaroxaban can be decreased when it is combined with Bosentan.
Brigatinib
The serum concentration of Rivaroxaban can be decreased when it is combined with Brigatinib.
Bromfenac
Bromfenac may increase the anticoagulant activities of Rivaroxaban.
Bromocriptine
The serum concentration of Bromocriptine can be increased when it is combined with Rivaroxaban.
Bufexamac
Bufexamac may increase the anticoagulant activities of Rivaroxaban.
Cabergoline
The serum concentration of Cabergoline can be increased when it is combined with Rivaroxaban.
Cangrelor
Cangrelor may increase the anticoagulant activities of Rivaroxaban.
Carbamazepine
The serum concentration of Rivaroxaban can be decreased when it is combined with Carbamazepine.
Carprofen
Carprofen may increase the anticoagulant activities of Rivaroxaban.
Celecoxib
Celecoxib may increase the anticoagulant activities of Rivaroxaban.
Ceritinib
The serum concentration of Rivaroxaban can be increased when it is combined with Ceritinib.
Certoparin
Certoparin may increase the anticoagulant activities of Rivaroxaban.
Chloroquine
Chloroquine may increase the anticoagulant activities of Rivaroxaban.
Chlorotrianisene
The serum concentration of Chlorotrianisene can be decreased when it is combined with Rivaroxaban.
Choline Magnesium Trisalicyclate
Choline magnesium trisalicylate may increase the anticoagulant activities of Rivaroxaban.
Cilostazol
Cilostazol may increase the anticoagulant activities of Rivaroxaban.
Citric Acid
Citric Acid may increase the anticoagulant activities of Rivaroxaban.
Citric Acid, Anhydrous
Citric Acid may increase the anticoagulant activities of Rivaroxaban.
Clarithromycin
The serum concentration of Rivaroxaban can be increased when it is combined with Clarithromycin.
Clemastine
The metabolism of Rivaroxaban can be decreased when combined with Clemastine.
Clomipramine
The serum concentration of Clomipramine can be increased when it is combined with Rivaroxaban.
Clonixin
Clonixin may increase the anticoagulant activities of Rivaroxaban.
Clopidogrel
Clopidogrel may increase the anticoagulant activities of Rivaroxaban.
Clotrimazole
The metabolism of Rivaroxaban can be decreased when combined with Clotrimazole.
Cobicistat
The metabolism of Rivaroxaban can be decreased when combined with Cobicistat.
COLLAGENASE
The risk or severity of adverse effects can be increased when Rivaroxaban is combined with Collagenase clostridium histolyticum.
collagenase Clostridium histolyticum
The risk or severity of adverse effects can be increased when Rivaroxaban is combined with Collagenase clostridium histolyticum.
Conivaptan
The serum concentration of Conivaptan can be increased when it is combined with Rivaroxaban.
Crizotinib
The metabolism of Rivaroxaban can be decreased when combined with Crizotinib.
Curcumin
Curcumin may increase the anticoagulant activities of Rivaroxaban.
Cyclobenzaprine
The serum concentration of Cyclobenzaprine can be increased when it is combined with Rivaroxaban.
Cyclophosphamide
The risk or severity of adverse effects can be increased when Rivaroxaban is combined with Cyclophosphamide.
Cyclophosphamide Anhydrous
The risk or severity of adverse effects can be increased when Rivaroxaban is combined with Cyclophosphamide.
Cyclosporine
The serum concentration of Cyclosporine can be increased when it is combined with Rivaroxaban.
Dabigatran Etexilate
Dabigatran etexilate may increase the anticoagulant activities of Rivaroxaban.
Dabrafenib
The serum concentration of Rivaroxaban can be decreased when it is combined with Dabrafenib.
Dalteparin
Dalteparin may increase the anticoagulant activities of Rivaroxaban.
Danaparoid
Danaparoid may increase the anticoagulant activities of Rivaroxaban.
Darunavir
The metabolism of Rivaroxaban can be decreased when combined with Darunavir.
Dasatinib
Dasatinib may increase the anticoagulant activities of Rivaroxaban.
Dasatinib Anhydrous
Dasatinib may increase the anticoagulant activities of Rivaroxaban.
Deferasirox
The serum concentration of Rivaroxaban can be decreased when it is combined with Deferasirox.
Defibrotide
Defibrotide may increase the anticoagulant activities of Rivaroxaban.
Delavirdine
The serum concentration of Delavirdine can be decreased when it is combined with Rivaroxaban.
Deoxycholate
The risk or severity of adverse effects can be increased when Rivaroxaban is combined with Deoxycholic Acid.
Deoxycholic Acid
The risk or severity of adverse effects can be increased when Rivaroxaban is combined with Deoxycholic Acid.
Desipramine
The serum concentration of Desipramine can be increased when it is combined with Rivaroxaban.
Desirudin
Desirudin may increase the anticoagulant activities of Rivaroxaban.
Desogestrel
The therapeutic efficacy of Rivaroxaban can be decreased when used in combination with Desogestrel.
Dextran
Dextran may increase the anticoagulant activities of Rivaroxaban.
Dextran 40
Dextran 40 may increase the anticoagulant activities of Rivaroxaban.
Dextran 70
Dextran 70 may increase the anticoagulant activities of Rivaroxaban.
Dextran 75
Dextran 75 may increase the anticoagulant activities of Rivaroxaban.
Diclofenac
Diclofenac may increase the anticoagulant activities of Rivaroxaban.
Dicumarol
Dicoumarol may increase the anticoagulant activities of Rivaroxaban.
Dienestrol
The serum concentration of Dienestrol can be decreased when it is combined with Rivaroxaban.
Dienogest
The therapeutic efficacy of Rivaroxaban can be decreased when used in combination with Dienogest.
Diethylstilbestrol
The serum concentration of Diethylstilbestrol can be decreased when it is combined with Rivaroxaban.
Diflunisal
Diflunisal may increase the anticoagulant activities of Rivaroxaban.
Digoxin
The serum concentration of Digoxin can be increased when it is combined with Rivaroxaban.
Dihydroergotamine
The metabolism of Rivaroxaban can be decreased when combined with Dihydroergotamine.
Diltiazem
The metabolism of Diltiazem can be decreased when combined with Rivaroxaban.
Dipyridamole
Dipyridamole may increase the anticoagulant activities of Rivaroxaban.
Dipyrone
Metamizole may increase the anticoagulant activities of Rivaroxaban.
Dothiepin
The serum concentration of Dosulepin can be increased when it is combined with Rivaroxaban.
Doxepin
The serum concentration of Doxepin can be increased when it is combined with Rivaroxaban.
Doxycycline
The metabolism of Rivaroxaban can be decreased when combined with Doxycycline.
Doxycycline Anhydrous
The metabolism of Rivaroxaban can be decreased when combined with Doxycycline.
Dronedarone
The metabolism of Rivaroxaban can be decreased when combined with Dronedarone.
Drotrecogin Alfa
Drotrecogin alfa may increase the anticoagulant activities of Rivaroxaban.
Droxicam
Droxicam may increase the anticoagulant activities of Rivaroxaban.
Dydrogesterone
The therapeutic efficacy of Rivaroxaban can be decreased when used in combination with Dydrogesterone.
Dyphylline
The serum concentration of Dyphylline can be decreased when it is combined with Rivaroxaban.
Edetic Acid
Edetic Acid may increase the anticoagulant activities of Rivaroxaban.
Edoxaban
Edoxaban may increase the anticoagulant activities of Rivaroxaban.
Enfuvirtide
The serum concentration of Enfuvirtide can be increased when it is combined with Rivaroxaban.
Enoxaparin
Enoxaparin may increase the anticoagulant activities of Rivaroxaban.
Enoxaparin sodium
Enoxaparin may increase the anticoagulant activities of Rivaroxaban.
Enzalutamide
The serum concentration of Rivaroxaban can be decreased when it is combined with Enzalutamide.
Epinastine
Epinastine may increase the anticoagulant activities of Rivaroxaban.
Epoprostenol
Epoprostenol may increase the anticoagulant activities of Rivaroxaban.
Eptifibatide
Eptifibatide may increase the anticoagulant activities of Rivaroxaban.
Equol, (-)-
Equol may decrease the anticoagulant activities of Rivaroxaban.
ergoloid mesylates, USP
The serum concentration of Ergoloid mesylate can be increased when it is combined with Rivaroxaban.
Ergonovine
The serum concentration of Ergonovine can be increased when it is combined with Rivaroxaban.
Ergotamine
The serum concentration of Ergotamine can be increased when it is combined with Rivaroxaban.
Erythromycin
The serum concentration of Rivaroxaban can be increased when it is combined with Erythromycin.
Estradiol
The serum concentration of Estradiol can be decreased when it is combined with Rivaroxaban.
Estradiol acetate
Estradiol acetate may decrease the anticoagulant activities of Rivaroxaban.
Estradiol Cypionate
Estradiol cypionate may decrease the anticoagulant activities of Rivaroxaban.
Estradiol Valerate
Estradiol valerate may decrease the anticoagulant activities of Rivaroxaban.
Estramustine
The serum concentration of Estramustine can be decreased when it is combined with Rivaroxaban.
Estriol
Estriol may decrease the anticoagulant activities of Rivaroxaban.
Estrogens, Conjugated (USP)
The serum concentration of Conjugated estrogens can be decreased when it is combined with Rivaroxaban.
Estrogens, Esterified (USP)
The serum concentration of Estrogens, esterified can be decreased when it is combined with Rivaroxaban.
Estrone
Estrone may decrease the anticoagulant activities of Rivaroxaban.
Etanercept
Etanercept may increase the anticoagulant activities of Rivaroxaban.
Ethinyl Estradiol
The serum concentration of Ethinyl Estradiol can be decreased when it is combined with Rivaroxaban.
Ethylenediaminetetraacetate
Edetic Acid may increase the anticoagulant activities of Rivaroxaban.
Ethynodiol
The therapeutic efficacy of Rivaroxaban can be decreased when used in combination with Ethynodiol.
Etodolac
Etodolac may increase the anticoagulant activities of Rivaroxaban.
Etofenamate
Etofenamate may increase the anticoagulant activities of Rivaroxaban.
Etonogestrel
The therapeutic efficacy of Rivaroxaban can be decreased when used in combination with Etonogestrel.
Etoricoxib
Etoricoxib may increase the anticoagulant activities of Rivaroxaban.
Etravirine
The serum concentration of Etravirine can be decreased when it is combined with Rivaroxaban.
Evening primrose oil
Evening primrose oil may increase the anticoagulant activities of Rivaroxaban.
Felbinac
Felbinac may increase the anticoagulant activities of Rivaroxaban.
Fenbufen
Fenbufen may increase the anticoagulant activities of Rivaroxaban.
Fenoprofen
Fenoprofen may increase the anticoagulant activities of Rivaroxaban.
Ferulic Acid
Ferulic acid may increase the anticoagulant activities of Rivaroxaban.
Fibrinolysis Inhibitor
The therapeutic efficacy of Rivaroxaban can be decreased when used in combination with Aprotinin.
Floctafenine
Floctafenine may increase the anticoagulant activities of Rivaroxaban.
Fluconazole
The metabolism of Rivaroxaban can be decreased when combined with Fluconazole.
Fluindione
Fluindione may increase the anticoagulant activities of Rivaroxaban.
Flurbiprofen
Flurbiprofen may increase the anticoagulant activities of Rivaroxaban.
Fluvoxamine
The metabolism of Rivaroxaban can be decreased when combined with Fluvoxamine.
Fondaparinux
Fondaparinux may increase the anticoagulant activities of Rivaroxaban.
Fondaparinux sodium
Fondaparinux sodium may increase the anticoagulant activities of Rivaroxaban.
Fosamprenavir
The metabolism of Rivaroxaban can be decreased when combined with Fosamprenavir.
Fosaprepitant
The serum concentration of Rivaroxaban can be increased when it is combined with Fosaprepitant.
Fosphenytoin
The serum concentration of Rivaroxaban can be decreased when it is combined with Fosphenytoin.
Fusidate
The serum concentration of Rivaroxaban can be increased when it is combined with Fusidic Acid.
Fusidic Acid
The serum concentration of Rivaroxaban can be increased when it is combined with Fusidic Acid.
Garlic Allergenic Extract
The serum concentration of Rivaroxaban can be decreased when it is combined with Garlic.
Genistein
Genistein may decrease the anticoagulant activities of Rivaroxaban.
Gestodene
The therapeutic efficacy of Rivaroxaban can be decreased when used in combination with Gestodene.
Gestrinone
The therapeutic efficacy of Rivaroxaban can be decreased when used in combination with Gestrinone.
Hemin
Hemin may increase the anticoagulant activities of Rivaroxaban.
Heparin
Heparin may increase the anticoagulant activities of Rivaroxaban.
hydroxyprogesterone caproate (USP)
The therapeutic efficacy of Rivaroxaban can be decreased when used in combination with Hydroxyprogesterone caproate.
Hydroxytyrosol
Hydroxytyrosol may increase the anticoagulant activities of Rivaroxaban.
Hypoxis hemerocallidea root extract
The serum concentration of Rivaroxaban can be decreased when it is combined with St. John's Wort.
Ibritumomab Tiuxetan
The risk or severity of adverse effects can be increased when Rivaroxaban is combined with Ibritumomab tiuxetan.
Ibrutinib
The risk or severity of adverse effects can be increased when Ibrutinib is combined with Rivaroxaban.
Ibuprofen
Ibuprofen may increase the anticoagulant activities of Rivaroxaban.
Icatibant
Icatibant may increase the anticoagulant activities of Rivaroxaban.
Icosapent Ethyl
Icosapent ethyl may increase the anticoagulant activities of Rivaroxaban.
Idelalisib
The serum concentration of Rivaroxaban can be increased when it is combined with Idelalisib.
Ifenprodil
Ifenprodil may increase the anticoagulant activities of Rivaroxaban.
Iloprost
Iloprost may increase the anticoagulant activities of Rivaroxaban.
Imatinib
The metabolism of Rivaroxaban can be decreased when combined with Imatinib.
Imipramine
The serum concentration of Imipramine can be increased when it is combined with Rivaroxaban.
Indinavir
The metabolism of Rivaroxaban can be decreased when combined with Indinavir.
INDINAVIR ANHYDROUS
The metabolism of Rivaroxaban can be decreased when combined with Indinavir.
Indobufen
Indobufen may increase the anticoagulant activities of Rivaroxaban.
Indomethacin
Indomethacin may increase the anticoagulant activities of Rivaroxaban.
Isavuconazole
The serum concentration of Rivaroxaban can be increased when it is combined with Isavuconazole.
Isavuconazonium
The metabolism of Rivaroxaban can be decreased when combined with Isavuconazonium.
Isradipine
The metabolism of Rivaroxaban can be decreased when combined with Isradipine.
Itraconazole
The metabolism of Rivaroxaban can be decreased when combined with Itraconazole.
Ivacaftor
The serum concentration of Rivaroxaban can be increased when it is combined with Ivacaftor.
Kebuzone
Kebuzone may increase the anticoagulant activities of Rivaroxaban.
Ketanserin
Ketanserin may increase the anticoagulant activities of Rivaroxaban.
Ketoconazole
The metabolism of Rivaroxaban can be decreased when combined with Ketoconazole.
Ketoprofen
Ketoprofen may increase the anticoagulant activities of Rivaroxaban.
Ketorolac
Ketorolac may increase the anticoagulant activities of Rivaroxaban.
Leflunomide
Leflunomide may increase the anticoagulant activities of Rivaroxaban.
Lepirudin
Lepirudin may increase the anticoagulant activities of Rivaroxaban.
Levonorgestrel
The therapeutic efficacy of Rivaroxaban can be decreased when used in combination with Levonorgestrel.
Limonene, (+)-
(4R)-limonene may increase the anticoagulant activities of Rivaroxaban.
Lopinavir
The metabolism of Rivaroxaban can be decreased when combined with Lopinavir.
Lornoxicam
Lornoxicam may increase the anticoagulant activities of Rivaroxaban.
Lovastatin
The serum concentration of Lovastatin can be increased when it is combined with Rivaroxaban.
Loxoprofen
Loxoprofen may increase the anticoagulant activities of Rivaroxaban.
Luliconazole
The serum concentration of Rivaroxaban can be increased when it is combined with Luliconazole.
Lumacaftor
The serum concentration of Rivaroxaban can be decreased when it is combined with Lumacaftor.
Magnesium Salicylate
Magnesium salicylate may increase the anticoagulant activities of Rivaroxaban.
Masoprocol
Masoprocol may increase the anticoagulant activities of Rivaroxaban.
Meclofenamate
Meclofenamic acid may increase the anticoagulant activities of Rivaroxaban.
Meclofenamic Acid
Meclofenamic acid may increase the anticoagulant activities of Rivaroxaban.
Medrogestone
The therapeutic efficacy of Rivaroxaban can be decreased when used in combination with Medrogestone.
Medroxyprogesterone Acetate
The therapeutic efficacy of Rivaroxaban can be decreased when used in combination with Medroxyprogesterone acetate.
Mefenamic Acid
Mefenamic acid may increase the anticoagulant activities of Rivaroxaban.
Megestrol Acetate
The therapeutic efficacy of Rivaroxaban can be decreased when used in combination with Megestrol acetate.
Meloxicam
Meloxicam may increase the anticoagulant activities of Rivaroxaban.
Meperidine
The risk or severity of adverse effects can be increased when Rivaroxaban is combined with Pethidine.
Mesalamine
Mesalazine may increase the anticoagulant activities of Rivaroxaban.
Mestranol
The serum concentration of Mestranol can be decreased when it is combined with Rivaroxaban.
Methyl Salicylate
Methyl salicylate may increase the anticoagulant activities of Rivaroxaban.
Methylergonovine
The serum concentration of Methylergometrine can be increased when it is combined with Rivaroxaban.
Midazolam
The serum concentration of Midazolam can be increased when it is combined with Rivaroxaban.
Mifepristone
The serum concentration of Rivaroxaban can be increased when it is combined with Mifepristone.
Milrinone
Milrinone may increase the anticoagulant activities of Rivaroxaban.
Mirtazapine
The serum concentration of Mirtazapine can be increased when it is combined with Rivaroxaban.
Mitotane
The serum concentration of Rivaroxaban can be decreased when it is combined with Mitotane.
MYCOPHENOLATE
Mycophenolic acid may increase the anticoagulant activities of Rivaroxaban.
Mycophenolate Mofetil
Mycophenolate mofetil may increase the anticoagulant activities of Rivaroxaban.
Mycophenolic Acid
Mycophenolic acid may increase the anticoagulant activities of Rivaroxaban.
Nabumetone
Nabumetone may increase the anticoagulant activities of Rivaroxaban.
Nadroparin
Nadroparin may increase the anticoagulant activities of Rivaroxaban.
Naftifine
Naftifine may increase the anticoagulant activities of Rivaroxaban.
Naproxen
Naproxen may increase the anticoagulant activities of Rivaroxaban.
Nefazodone
The serum concentration of Nefazodone can be increased when it is combined with Rivaroxaban.
Nelfinavir
The metabolism of Rivaroxaban can be decreased when combined with Nelfinavir.
Nepafenac
Nepafenac may increase the anticoagulant activities of Rivaroxaban.
Netupitant
The serum concentration of Rivaroxaban can be increased when it is combined with Netupitant.
Nevirapine
The serum concentration of Rivaroxaban can be decreased when it is combined with Nevirapine.
Niflumic Acid
Niflumic Acid may increase the anticoagulant activities of Rivaroxaban.
Nilotinib
The metabolism of Rivaroxaban can be decreased when combined with Nilotinib.
Nimesulide
Nimesulide may increase the anticoagulant activities of Rivaroxaban.
Nintedanib
The risk or severity of adverse effects can be increased when Rivaroxaban is combined with Nintedanib.
Nomegestrol
The therapeutic efficacy of Rivaroxaban can be decreased when used in combination with Nomegestrol.
Norethindrone
The therapeutic efficacy of Rivaroxaban can be decreased when used in combination with Norethisterone.
Nortriptyline
The serum concentration of Nortriptyline can be increased when it is combined with Rivaroxaban.
Obinutuzumab
The risk or severity of adverse effects can be increased when Rivaroxaban is combined with Obinutuzumab.
Oenothera biennis seed extract
Evening primrose oil may increase the anticoagulant activities of Rivaroxaban.
Olaparib
The metabolism of Rivaroxaban can be decreased when combined with Olaparib.
Olopatadine
Olopatadine may increase the anticoagulant activities of Rivaroxaban.
Olsalazine
Olsalazine may increase the anticoagulant activities of Rivaroxaban.
Omacetaxine Mepesuccinate
The risk or severity of bleeding can be increased when Rivaroxaban is combined with Omacetaxine mepesuccinate.
Omega-3 Fatty Acids
Omega-3 fatty acids may increase the anticoagulant activities of Rivaroxaban.
Opipramol
The serum concentration of Opipramol can be increased when it is combined with Rivaroxaban.
Osimertinib
The serum concentration of Rivaroxaban can be increased when it is combined with Osimertinib.
Oxaprozin
Oxaprozin may increase the anticoagulant activities of Rivaroxaban.
Oxyphenbutazone
Oxyphenbutazone may increase the anticoagulant activities of Rivaroxaban.
Palbociclib
The serum concentration of Rivaroxaban can be increased when it is combined with Palbociclib.
Parecoxib
Parecoxib may increase the anticoagulant activities of Rivaroxaban.
Parnaparin
Parnaparin may increase the anticoagulant activities of Rivaroxaban.
Parthenolide
Parthenolide may increase the anticoagulant activities of Rivaroxaban.
Pentaerythritol Tetranitrate
Pentaerythritol Tetranitrate may increase the anticoagulant activities of Rivaroxaban.
Pentobarbital
The serum concentration of Rivaroxaban can be decreased when it is combined with Pentobarbital.
Pentosan Polysulfate
Pentosan Polysulfate may increase the anticoagulant activities of Rivaroxaban.
Pentoxifylline
Pentoxifylline may increase the anticoagulant activities of Rivaroxaban.
Phenindione
Phenindione may increase the anticoagulant activities of Rivaroxaban.
Phenobarbital
The serum concentration of Rivaroxaban can be decreased when it is combined with Phenobarbital.
Phenprocoumon
Phenprocoumon may increase the anticoagulant activities of Rivaroxaban.
Phenylbutazone
Phenylbutazone may increase the anticoagulant activities of Rivaroxaban.
Phenytoin
The serum concentration of Rivaroxaban can be decreased when it is combined with Phenytoin.
Phospholipids
Omega-3 fatty acids may increase the anticoagulant activities of Rivaroxaban.
Pimecrolimus
Pimecrolimus may increase the anticoagulant activities of Rivaroxaban.
Pirfenidone
Pirfenidone may increase the anticoagulant activities of Rivaroxaban.
Piroxicam
Piroxicam may increase the anticoagulant activities of Rivaroxaban.
Piroxicam-Beta-Cyclodextrin
Piroxicam may increase the anticoagulant activities of Rivaroxaban.
Plasmin
Fibrinolysin may increase the anticoagulant activities of Rivaroxaban.
Polyestradiol Phosphate
Polyestradiol phosphate may decrease the anticoagulant activities of Rivaroxaban.
Posaconazole
The metabolism of Rivaroxaban can be decreased when combined with Posaconazole.
Prasugrel
Prasugrel may increase the anticoagulant activities of Rivaroxaban.
Primidone
The serum concentration of Rivaroxaban can be decreased when it is combined with Primidone.
Progesterone
The therapeutic efficacy of Rivaroxaban can be decreased when used in combination with Progesterone.
Promestriene
Promestriene may decrease the anticoagulant activities of Rivaroxaban.
protein C, human
Protein C may increase the anticoagulant activities of Rivaroxaban.
protein S, human
Protein S human may increase the anticoagulant activities of Rivaroxaban.
Protocatechualdehyde
Protocatechualdehyde may increase the anticoagulant activities of Rivaroxaban.
Protriptyline
The serum concentration of Protriptyline can be increased when it is combined with Rivaroxaban.
Quinestrol
Quinestrol may decrease the anticoagulant activities of Rivaroxaban.
Ranolazine
The serum concentration of Rivaroxaban can be increased when it is combined with Ranolazine.
Resveratrol
Resveratrol may increase the anticoagulant activities of Rivaroxaban.
Reteplase
Reteplase may increase the anticoagulant activities of Rivaroxaban.
Reviparin
Reviparin may increase the anticoagulant activities of Rivaroxaban.
Reviparin sodium
Reviparin may increase the anticoagulant activities of Rivaroxaban.
Ribociclib
The serum concentration of Rivaroxaban can be increased when it is combined with Ribociclib.
Rifabutin
The serum concentration of Rivaroxaban can be decreased when it is combined with Rifabutin.
Rifampin
The serum concentration of Rivaroxaban can be decreased when it is combined with Rifampicin.
Rifapentine
The serum concentration of Rivaroxaban can be decreased when it is combined with Rifapentine.
Riociguat
The serum concentration of Riociguat can be increased when it is combined with Rivaroxaban.
Rofecoxib
Rofecoxib may increase the anticoagulant activities of Rivaroxaban.
Rosiglitazone
Rosiglitazone may increase the anticoagulant activities of Rivaroxaban.
Rucaparib
The metabolism of Rivaroxaban can be decreased when combined with Rucaparib.
Salicylamide
Salicylamide may increase the anticoagulant activities of Rivaroxaban.
Salicylic Acid
Salicylic acid may increase the anticoagulant activities of Rivaroxaban.
Salsalate
Salsalate may increase the anticoagulant activities of Rivaroxaban.
Saquinavir
The metabolism of Rivaroxaban can be decreased when combined with Saquinavir.
Saquinavir Mesylate
The metabolism of Rivaroxaban can be decreased when combined with Saquinavir.
Sarilumab
The therapeutic efficacy of Rivaroxaban can be decreased when used in combination with Sarilumab.
Selexipag
Selexipag may increase the anticoagulant activities of Rivaroxaban.
Serratiopeptidase
Serrapeptase may increase the anticoagulant activities of Rivaroxaban.
Sevoflurane
Sevoflurane may increase the anticoagulant activities of Rivaroxaban.
Sildenafil
The serum concentration of Sildenafil can be increased when it is combined with Rivaroxaban.
Siltuximab
The serum concentration of Rivaroxaban can be decreased when it is combined with Siltuximab.
Simeprevir
The serum concentration of Rivaroxaban can be increased when it is combined with Simeprevir.
Simvastatin
The serum concentration of Simvastatin can be increased when it is combined with Rivaroxaban.
ST. JOHN'S WORT EXTRACT
The serum concentration of Rivaroxaban can be decreased when it is combined with St. John's Wort.
Streptokinase
Streptokinase may increase the anticoagulant activities of Rivaroxaban.
Sugammadex
Sugammadex may increase the anticoagulant activities of Rivaroxaban.
Sulfasalazine
Sulfasalazine may increase the anticoagulant activities of Rivaroxaban.
Sulfisoxazole
The metabolism of Rivaroxaban can be decreased when combined with Sulfisoxazole.
Sulindac
Sulindac may increase the anticoagulant activities of Rivaroxaban.
Suprofen
Suprofen may increase the anticoagulant activities of Rivaroxaban.
synthetic conjugated estrogens, A
The serum concentration of Synthetic Conjugated Estrogens, A can be decreased when it is combined with Rivaroxaban.
synthetic conjugated estrogens, B
Synthetic Conjugated Estrogens, B may decrease the anticoagulant activities of Rivaroxaban.
Tacrolimus
The metabolism of Tacrolimus can be decreased when combined with Rivaroxaban.
Telaprevir
The metabolism of Rivaroxaban can be decreased when combined with Telaprevir.
Telithromycin
The metabolism of Rivaroxaban can be decreased when combined with Telithromycin.
Temsirolimus
The risk or severity of adverse effects can be increased when Rivaroxaban is combined with Temsirolimus.
Tenecteplase
Tenecteplase may increase the anticoagulant activities of Rivaroxaban.
Tenoxicam
Tenoxicam may increase the anticoagulant activities of Rivaroxaban.
Teriflunomide
Teriflunomide may increase the anticoagulant activities of Rivaroxaban.
Testosterone Cypionate
The therapeutic efficacy of Rivaroxaban can be increased when used in combination with Testosterone cypionate.
Testosterone Enanthate
The therapeutic efficacy of Rivaroxaban can be increased when used in combination with Testosterone enanthate.
Testosterone Undecanoate
The therapeutic efficacy of Rivaroxaban can be increased when used in combination with Testosterone undecanoate.
Theophylline
The serum concentration of Theophylline can be decreased when it is combined with Rivaroxaban.
Theophylline anhydrous
The serum concentration of Theophylline can be decreased when it is combined with Rivaroxaban.
Tianeptine
The serum concentration of Tianeptine can be increased when it is combined with Rivaroxaban.
Tiaprofenic Acid
Tiaprofenic acid may increase the anticoagulant activities of Rivaroxaban.
Tibolone
Tibolone may increase the anticoagulant activities of Rivaroxaban.
Ticagrelor
Ticagrelor may increase the anticoagulant activities of Rivaroxaban.
Ticlopidine
Ticlopidine may increase the anticoagulant activities of Rivaroxaban.
Tinzaparin
Tinzaparin may increase the anticoagulant activities of Rivaroxaban.
Tinzaparin sodium
Tinzaparin may increase the anticoagulant activities of Rivaroxaban.
Tipranavir
The serum concentration of Rivaroxaban can be decreased when it is combined with Tipranavir.
Tirofiban
Tirofiban may increase the anticoagulant activities of Rivaroxaban.
Tocilizumab
The serum concentration of Rivaroxaban can be decreased when it is combined with Tocilizumab.
Tolfenamic Acid
Tolfenamic Acid may increase the anticoagulant activities of Rivaroxaban.
Tolmetin
Tolmetin may increase the anticoagulant activities of Rivaroxaban.
Tositumomab
The risk or severity of adverse effects can be increased when Rivaroxaban is combined with Tositumomab.
Tranilast
Tranilast may increase the anticoagulant activities of Rivaroxaban.
Trapidil
Trapidil may increase the anticoagulant activities of Rivaroxaban.
Treprostinil
Treprostinil may increase the anticoagulant activities of Rivaroxaban.
Triazolam
The serum concentration of Triazolam can be increased when it is combined with Rivaroxaban.
Triflusal
Triflusal may increase the anticoagulant activities of Rivaroxaban.
Trimipramine
The serum concentration of Trimipramine can be increased when it is combined with Rivaroxaban.
Trolamine Salicylate
Trolamine salicylate may increase the anticoagulant activities of Rivaroxaban.
Troxerutin
Troxerutin may increase the anticoagulant activities of Rivaroxaban.
Urokinase
Urokinase may increase the anticoagulant activities of Rivaroxaban.
Valdecoxib
Valdecoxib may increase the anticoagulant activities of Rivaroxaban.
Valproate
The serum concentration of Valproic Acid can be decreased when it is combined with Rivaroxaban.
Valproic Acid
The serum concentration of Valproic Acid can be decreased when it is combined with Rivaroxaban.
Vemurafenib
The serum concentration of Rivaroxaban can be increased when it is combined with Vemurafenib.
Venlafaxine
The metabolism of Rivaroxaban can be decreased when combined with Venlafaxine.
Verapamil
The metabolism of Verapamil can be decreased when combined with Rivaroxaban.
Vitamin E
Vitamin E may increase the anticoagulant activities of Rivaroxaban.
Vorapaxar
The risk or severity of adverse effects can be increased when Vorapaxar is combined with Rivaroxaban.
Voriconazole
The metabolism of Rivaroxaban can be decreased when combined with Voriconazole.
Warfarin
Warfarin may increase the anticoagulant activities of Rivaroxaban.
Zidovudine
The serum concentration of Zidovudine can be decreased when it is combined with Rivaroxaban.
Zileuton
Zileuton may increase the anticoagulant activities of Rivaroxaban.
Ziprasidone
The metabolism of Rivaroxaban can be decreased when combined with Ziprasidone.
Zomepirac
Zomepirac may increase the anticoagulant activities of Rivaroxaban.
